Effect of Blood Pressure on the lipids and Percentage of Fatty Acids of Blood Serum
DOI:
https://doi.org/10.61841/hggv0185Keywords:
fatty acid, cholesterol ester, phospholipids, triglycerides, blood pressureAbstract
This study included (50) samples of high blood pressure males and females with ages between between(80-19) years and (50) samples of healthy people who are not infected with any apparent disease males and females were considered a control group of the same categories Age above. In this study, blood samples were collected for healthy people in the case of fasting and control group period for fasting group then the serum was separated, where the serum divided into two parts .The biochemical parameters in part one glucose(Glu), total cholesterol(TC), high-density lipoprotein cholesterol(HDL), low-density lipoprotein cholesterol(LDL),very low-density lipoprotein cholesterol(VLDL), triglyceride(TG) and phospholipids was measured by using kits obtained from regional and international suppliers.the measurement of percentage of fatty acids in the three parts (CE, TG, PL) was performed by Capillary Gas Chromatography (CGC). The results showed that there was a significant increase in the percentage and level of saturated fatty acids (SFA), a significant decrease in monounsaturated fatty acids (MUFA) and a significant decrease in polyunsaturated fatty acids (PUFA), in the cholesterol ester (CE) part of serum lipids for the fasting group compared with the control group.Also, the results of this study showed that there was a significant increase in (SFA), a significant decrease in (MUFA), and a significant increase in (PUFA) in triglyceride (TG) part in serum of the fasting group compared to the control group.The results showed that there was a significant increase in (SFA), a significant decrease in (MUFA) and a significant decrease in (PUFA) in phospholipids (PL) part in the serum for the hypertension group compared with the control group.
Downloads
References
1. Calder, PC, Dangour, AD, Diekman, C, Eilander, A, Koletzko, B, Meijer, GW, Mozaffarian, D, Niinikoski, H, Osendarp, SJ, Pietinen, P, Schuit, J, Uauy, R (2 010) Essential fats for future health. Eur J Clin Nutr. 64, Suppl. 4, S1–13.
2. Gebauer, SK, Psota, TL, Harris, WS & Kris-Etherton, PM (2006) n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 83, Suppl. 6, 1526S–1535S.
3-. Cook, H & McMaster, C (2002) Fatty acid desaturation and chain elongation in eukaryotes. In Biochemistry of Lipids, Lipoproteins and Membranes, 4th ed.,
pp. 181–204.
4- Biscione, F, Pignalberi, C, Totteri, A, Messina, F & Altamura, G (2007) Cardiovascular effects of omega-3 free fatty acids. Curr Vasc Pharmacol.
5- Cicero, AF, Ertek, S & Borghi, C (2009) Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management. Curr Vasc Pharmacol. 7, 330–337 .
6- Barry.A.,SearsH,.(2019) Dietary fat and blood pressure modifications in subjects with the metabolic syndrome in the dietary intervention LIPGENE study. J Nutr.
7- Folsom A. Ma J. Eckteidt J..Metabolism. .( 1996). 45:223-228
8- Murray R. Gramner D. Rodweu V. Harpers Biochemistry. .(2000). 25th ed.
Appleton and Lange
9- Ma J. Shahar E.Blood pressure ( 2019). Am.J.Clin. Nutr.;62:564- 571.
10. Guo, S.X.; Yang, Z.M.; Zhang, J.Y.; Guo, H.; Zhang, Y.H.; Xu, S.Z.; Niu, Q.
Chin. J. Hypertens. .( 2017)., 18, 459–464
11. Boden, G. Obesity.( 2017)., Diabetes Obes., 18, 139–143
12. Tabara, Y.; Takahashi, Y.; Kawaguchi, T.; Setoh, K.; Terao, C.; Yamada, R.; Kosuqi, .( 2018) Hypertension, 64, 1212–1218.
13. Fukuchi S. Hamaguchi K. Seike M.( 2018).. Exp.Bio.& Mid. ;229:480-490
14. Iso H. and Sato S. .(2017). Stroke.; 33:2086-2093
15. Leonard T.and Kathleen R. .( 2000).The ways and means of statistics. Harcourt Brac Jovanovich ;pp490-495
16. Ling H. Katherine C.( 2018). .Biochem.Cell Biol. ;82: 175-180
17. Freire R. Cardose A. Ferreria S. (2017). Diabetes Care.;28:1770-1780
18. Vessby B. Boberg M. Andersson.( 2016). A. Ann. Acad. Sci. ;967:180-195
19. Guo, H.; D.S.; Xu, S.Z.; Sun, F.; Hu, A.R.; Yang, Z.M. (2018). Chin. J.
Epidemiol., 31, 747–750
20. Tanne S . David A.( 2018).. Circulation .;104:24
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
